AT469986T - SENP1 as a marker for cancer

22 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims
Document	Office	Kind	Date
56922004	United States of America	P	2004-05-06
59931804	United States of America	P	2004-08-05
2005004839	European Patent Office (EPO)	W	2005-05-04

Family members, oldest first
Document	Office	Kind
CA2564484A1	Canada	A1	2005-11-17
WO2005108603A1	World Intellectual Property Organization (WIPO)	A1	2005-11-17
US2006014171A1	United States of America	A1	2006-01-19
EP1761640A1	European Patent Office (EPO)	A1	2007-03-14
CN101010434A	China	A	2007-08-01
JP2008500028A	Japan	A	2008-01-10
US2009162846A1	United States of America	A1	2009-06-25
EP2110439A1	European Patent Office (EPO)	A1	2009-10-21
EP1761640B1	European Patent Office (EPO)	B1	2010-06-02
AT469986TThis record	Austria	T	2010-06-15
ATE469986T1	Austria	T1	2010-06-15
DE602005021634D1	Germany	D1	2010-07-15
US7776539B2	United States of America	B2	2010-08-17
ES2345720T3	Spain	T3	2010-09-30
EP2258876A1	European Patent Office (EPO)	A1	2010-12-08
US7939251B2	United States of America	B2	2011-05-10
JP4729038B2	Japan	B2	2011-07-20
EP2258876B1	European Patent Office (EPO)	B1	2012-07-11
ES2391079T3	Spain	T3	2012-11-21
CA2564484C	Canada	C	2013-01-08
EP2110439B1	European Patent Office (EPO)	B1	2014-03-12
ES2464719T3	Spain	T3	2014-06-03

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2011-01-15	Publication of translation of european patent specificationUEP	UEP

CPC, 5: C12Q1/6886
A61P35/00
C12Q2600/136
A61P43/00
C12Q2600/158
Filled: the office’s first classification
IPC, 1: C12Q1 68

SENP1 as a marker for cancer